Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: An analysis of 19 cases

American Journal of Kidney Diseases

Volumn 63, Issue 1, 2014, Pages 40-48

  Fakhouri, Fadi ^a   Delmas, Yahsou ^b   Provot, François ^c   Barbet, Christelle ^d   Karras, Alexandre ^e   Makdassi, Raifah ^f   Courivaud, Cécile ^g   Rifard, Khair ^h   Servais, Aude ⁱ   Allard, Catherine ^j   Besson, Virginie ^k   Cousin, Maud ^k   Châtelet, Valérie ^l   Goujon, Jean Michel ^m   Coindre, Jean Philippe ^h   Laurent, Guillaume ^h   Loirat, Chantal ⁿ   Frémeaux Bacchi, Véronique ⁿ  

^a INSERM   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f AMIENS UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HOSPITAL OF BESANÇON   (France)

^h Department of Nephrology CH de Bourges ^*  (France)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j Centre Hospitalier Regional Metz Thionville   (France)

^k ANGERS UNIVERSITY HOSPITAL   (France)

^l CAEN UNIVERSITY HOSPITAL   (France)

^m POITIERS UNIVERSITY HOSPITAL   (France)

ⁿ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; CREATININE; ECULIZUMAB;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CREATININE BLOOD LEVEL; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GENE MUTATION; GLOMERULUS FILTRATION RATE; HEMOLYSIS; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; MIDDLE AGED; PLASMAPHERESIS; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; YOUNG ADULT;

ATYPICAL HEMOLYTIC UREMIC SYNDROME; COMPLEMENT; ECULIZUMAB; THROMBOTIC MICROANGIOPATHY;

ACUTE KIDNEY INJURY; ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; BIOPSY; CREATININE; DRUG MONITORING; FEMALE; FRANCE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOLOGIC FACTORS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; PLATELET COUNT; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84896101449     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.07.011     Document Type: Article

References (18)

1. F. Fakhouri, and V. Fremeaux-Bacchi Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura? Nat Clin Pract Nephrol 3 12 2007 679 687
2. V. Fremeaux-Bacchi, F. Fakhouri, and A. Garnier et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults Clin J Am Soc Nephrol 8 4 2012 554 562
3. M. Noris, J. Caprioli, and E. Bresin et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype Clin J Am Soc Nephrol 5 10 2010 1844 1859
4. J. Zuber, M. Le Quintrec, and S. Krid et al. Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation Am J Transplant 12 12 2012 3337 3354
5. E. Bresin, E. Daina, and M. Noris et al. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background Clin J Am Soc Nephrol 1 1 2006 88 99
6. M. Le Quintrec, J. Zuber, and B. Moulin et al. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome Am J Transplant 13 3 2013 663 675
7. M. Noris, and G. Remuzzi Atypical hemolytic-uremic syndrome N Engl J Med 361 17 2009 1676 1687
8. J. Zuber, F. Fakhouri, L.T. Roumenina, C. Loirat, and V. Fremeaux-Bacchi Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies Nat Rev Nephrol 8 11 2012 643 657
9. M.A. Dragon-Durey, C. Blanc, A. Garnier, J. Hofer, S.K. Sethi, and L.B. Zimmerhackl Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS Semin Thromb Hemost 36 6 2010 633 640
10. C. Parker Eculizumab for paroxysmal nocturnal haemoglobinuria Lancet 373 9665 2009 759 767
11. C.M. Legendre, C. Licht, and P. Muus et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome N Engl J Med 368 23 2013 2169 2181
12. F. Fakhouri, L. Roumenina, and F. Provot et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations J Am Soc Nephrol 21 5 2010 859 867
13. M. Furlan, R. Robles, and M. Galbusera et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome N Engl J Med 339 22 1998 1578 1584
14. C. Frank, D. Werber, and J.P. Cramer et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany N Engl J Med 365 19 2011 1771 1780
15. V. Eremina, J.A. Jefferson, and J. Kowalewska et al. VEGF inhibition and renal thrombotic microangiopathy N Engl J Med 358 11 2008 1129 1136
16. K. Lechner, and H.L. Obermeier Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases Medicine 91 4 2012 195 205
17. V. Majithia, and V. Harisdangkul Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: a frequent and severe consequence of active disease Rheumatology 45 9 2006 1170 1171
18. M. Sallee, K. Ismail, and F. Fakhouri et al. Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome BMC Nephrol 14 2013 3